Visano Theranostics has been selected for JumpStart's Trailblazer HealthTech Accelerator, a prestigious 3-month program that provides healthcare startups with expert mentorship, regulatory guidance, and access to up to $275,000 in development services.

The Visano Solution

Enhancing The Future Of Ultrasound Imaging.

Visano Theranostics is transforming the landscape of medical imaging and therapy with our innovative nanobubble technology, designed to outperform traditional ultrasound contrast agents. Our nanobubbles last up to 20 times longer than microbubbles, providing extended imaging windows and enhanced diagnostic precision. Their nanoscale size allows for superior tissue penetration and the ability to target both vascular and extravascular biomarkers, unlocking applications beyond the reach of conventional agents. With a high yield production process and tunable properties, our platform supports a broad range of clinical uses, from foundational imaging to targeted diagnostics and ultrasound-mediated theranostics. This versatility positions Visano as a leader in advancing cost-effective, real-time ultrasound solutions that improve patient outcomes, reduce healthcare costs, and expand access to cutting-edge theranostics globally.
Nanobubbles Images

The Visano Solution

We are developing a new ultrasound contrast agent called nanobubble (NB) to help improve the detection and treatment of prostate cancer. These nanobubbles specifically target PSMA, a marker found in high amounts on prostate cancer cells, which allows for precise detection and treatment that focuses only on the cancer, leaving healthy cells unharmed. 

Nanobubbles can be used in several ways: 

They can help clearly identify tumors during standard prostate needle biopsy using transrectal ultrasound. 

They can guide focal therapies like high-intensity focused ultrasound (HIFU) to precisely target and destroy tumors. 

They can be used to evaluate the success of ablation therapies. 

Using a stronger ultrasound pulse, nanobubbles can also deliver targeted therapy (called TNT) that bursts the bubbles and destroys cancer cells directly. 

Overall, nanobubbles can enhance the capabilities of current ultrasound technology, making prostate cancer diagnosis and treatment more accurate, less invasive, and fewer side effects. 

Meet Our Team

James P. Basilion, Ph.D.

James P. Basilion, Ph.D.

Inventor, Co-founder​

Professor of Radiology & BME, CWRU​ ​
30+ years of experience in molecular oncology, translational tech​

Agata A. Exner, Ph.D.

Agata A. Exner, Ph.D.

Inventor, Co-founder​

Director of the CWRU Center for Imaging Research and a leading expert in molecular imaging and theranostics.

Michael J. Haag, MS, MBA

Michael J. Haag, MS, MBA

Co-founder, Chief Executive Officer

Expert in tech transfer and startups with 25+ years experience, formerly at CWRU, now leading innovation through TherExel LLC.

About Our Technologies

Explore how nanobubble innovation is driving breakthroughs in cancer diagnosis and precision therapy.

Why Nanobubbles?

VISANO: Revolutionizing Cancer Diagnosis and Treatment with Nanobubbles In the ever-evolving fight against cancer, innovation is crucial. Traditional diagnostic tools.

Lead Application.

Revolutionizing Prostate Cancer Diagnosis and Treatment with Nanobubble Contrast Agents Prostate cancer remains one of the most commonly diagnosed cancers.

Visano’s Solution: Targeted Nanobubble Therapy.

A New Frontier in Precision Oncology Prostate cancer continues to be one of the most prevalent cancers in men worldwide.

Our Publications

Explore peer-reviewed studies and scientific breakthroughs highlighting the cutting-edge role of nanobubbles in diagnostics, cancer imaging, and more.

Our Publications

Explore peer-reviewed studies and scientific breakthroughs highlighting the cutting-edge role of nanobubbles in diagnostics, cancer imaging, and more.

Latest News & Blogs

Discover recent breakthroughs, trends, and real-world applications of nanobubble technology across industries.

Visano’s Solution: Targeted Nanobubble Therapy

A New Frontier in Precision Oncology Prostate cancer continues to be one of the most prevalent cancers in men worldwide, […]

What We Solve and What We Do

Revolutionizing Prostate Cancer Diagnosis and Treatment with Nanobubble Contrast Agents Prostate cancer remains one of the most commonly diagnosed cancers […]

Why Nanobubbles?

VISANO: Revolutionizing Cancer Diagnosis and Treatment with Nanobubbles In the ever-evolving fight against cancer, innovation is crucial. Traditional diagnostic tools […]

Scroll to Top